Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...
Background Patients undergoing thoracoscopic pulmonary resection are prone to moderate-to-severe acute postoperative pain, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results